SG11201603407VA - Cell culture method - Google Patents

Cell culture method

Info

Publication number
SG11201603407VA
SG11201603407VA SG11201603407VA SG11201603407VA SG11201603407VA SG 11201603407V A SG11201603407V A SG 11201603407VA SG 11201603407V A SG11201603407V A SG 11201603407VA SG 11201603407V A SG11201603407V A SG 11201603407VA SG 11201603407V A SG11201603407V A SG 11201603407VA
Authority
SG
Singapore
Prior art keywords
cell culture
culture method
cell
culture
Prior art date
Application number
SG11201603407VA
Other languages
English (en)
Inventor
Marian June Sturm
Original Assignee
Isopogen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904257A external-priority patent/AU2013904257A0/en
Application filed by Isopogen Pty Ltd filed Critical Isopogen Pty Ltd
Publication of SG11201603407VA publication Critical patent/SG11201603407VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201603407VA 2013-11-04 2014-11-03 Cell culture method SG11201603407VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013904257A AU2013904257A0 (en) 2013-11-04 Cell culture method
PCT/AU2014/001031 WO2015061839A1 (en) 2013-11-04 2014-11-03 Cell culture method

Publications (1)

Publication Number Publication Date
SG11201603407VA true SG11201603407VA (en) 2016-05-30

Family

ID=53003004

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201603407VA SG11201603407VA (en) 2013-11-04 2014-11-03 Cell culture method

Country Status (13)

Country Link
US (2) US9868936B2 (de)
EP (1) EP3066193B1 (de)
JP (2) JP6643999B2 (de)
KR (1) KR102314825B1 (de)
CN (1) CN105765059B (de)
AU (1) AU2014344795B2 (de)
BR (1) BR112016009753B1 (de)
CA (1) CA2929333C (de)
IL (1) IL245392B (de)
MX (1) MX2016005824A (de)
RU (1) RU2016119489A (de)
SG (1) SG11201603407VA (de)
WO (1) WO2015061839A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3066193B1 (de) * 2013-11-04 2024-07-10 Isopogen Pty Ltd Zellkulturverfahren
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
JP7108537B2 (ja) * 2016-04-27 2022-07-28 ロート製薬株式会社 Ｃｄ２０１、ｃｄ４６、ｃｄ５６、ｃｄ１４７及びｃｄ１６５からなる群より選択される少なくとも１種の細胞表面マーカーを発現する間葉系幹細胞及びその調製方法、並びに上記間葉系幹細胞を含む医薬組成物及びその調製方法
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota
CN108925548A (zh) * 2017-05-24 2018-12-04 西比曼生物科技（香港）有限公司 一种冻存细胞制剂及细胞复苏方式
JPWO2020067443A1 (ja) * 2018-09-27 2021-08-30 テルモ株式会社 体細胞のシート化方法
CN110628700B (zh) * 2019-10-14 2023-10-17 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种用于筛选细胞培养条件的标准方法
EP4106776A1 (de) * 2020-02-19 2022-12-28 Mesoblast International Sàrl Verfahren zum behandeln der chronischen transplant-und-wirts-krankheit
JP7137883B2 (ja) * 2020-07-31 2022-09-15 株式会社Rainbow 自家血小板由来の血小板溶解物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027996A1 (en) * 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
ES2432118T3 (es) * 2001-02-14 2013-11-29 Abt Holding Company Células madre adultas multipotentes, fuentes de estas, métodos para obtenerlas y mantenerlas, métodos de diferenciación de estas, métodos de uso de estas y células derivadas de estas
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20070020242A1 (en) * 2003-03-27 2007-01-25 Ixion Biotechnology, Inc. Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
DE102004055615A1 (de) * 2004-11-16 2006-05-18 Universitätsklinikum Hamburg-Eppendorf In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung
US7972767B2 (en) * 2005-05-09 2011-07-05 Olympus Corporation Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis
US7989205B2 (en) * 2005-10-06 2011-08-02 American Cryostem Corporation Cell culture media, kits and methods of use
EP1795588A1 (de) * 2005-12-07 2007-06-13 Cellerix, S.L. Verwendung von aus Fettgewebe stammende mesenchymale Stammzellen zur Behandlung von Transplantat-gegen-Empfänger Krankheit
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
US20100272694A1 (en) * 2008-10-17 2010-10-28 Affiliated Hospital Of Ningxia Medical University Clinic compliant method for banking human placental mesenchymal cells
US20140106448A1 (en) * 2011-04-29 2014-04-17 Tissuetech, Inc. Methods of isolating cells
CN102965335A (zh) * 2011-09-01 2013-03-13 北京清美联创干细胞科技有限公司 用于间充质干细胞培养的试剂盒及其应用
EP3066193B1 (de) * 2013-11-04 2024-07-10 Isopogen Pty Ltd Zellkulturverfahren

Also Published As

Publication number Publication date
RU2016119489A (ru) 2017-12-11
MX2016005824A (es) 2016-11-18
EP3066193A1 (de) 2016-09-14
KR102314825B1 (ko) 2021-10-20
JP6947430B2 (ja) 2021-10-13
US9868936B2 (en) 2018-01-16
AU2014344795A1 (en) 2016-03-10
CA2929333A1 (en) 2015-05-07
US11041144B2 (en) 2021-06-22
EP3066193B1 (de) 2024-07-10
EP3066193A4 (de) 2017-04-19
JP2017501740A (ja) 2017-01-19
CN105765059B (zh) 2021-05-25
BR112016009753A2 (pt) 2018-05-02
KR20160070167A (ko) 2016-06-17
CA2929333C (en) 2023-09-12
US20150307844A1 (en) 2015-10-29
BR112016009753B1 (pt) 2023-11-28
IL245392B (en) 2018-10-31
IL245392A0 (en) 2016-06-30
AU2014344795B2 (en) 2016-05-26
JP6643999B2 (ja) 2020-02-12
WO2015061839A1 (en) 2015-05-07
CN105765059A (zh) 2016-07-13
JP2020022486A (ja) 2020-02-13
US20180112181A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
IL262833A (en) Metabolically enriched cell culture
IL241627B (en) A method for t-cell activation
IL246262A0 (en) Cell culture media
HK1219502A1 (zh) 片狀細胞培養物的製造方法
EP2968549A4 (de) Zellkulturverfahren
EP2971040A4 (de) Zellkulturverfahren
EP2971014A4 (de) Zellkulturverfahren
IL245392B (en) A method for cell culture
HK1221250A1 (zh) 用於培養細胞的結構件
EP2980207A4 (de) Zellsortierverfahren
EP2975110A4 (de) Zellkulturvorrichtung
EP2957630A4 (de) Undifferenziertes zelleliminationsverfahren
EP3024081A4 (de) Verfahren zur herstellung von zellen
GB201420277D0 (en) Cell culture system
PL2970845T3 (pl) Bioreaktor
GB201310031D0 (en) Cell
PL2978839T3 (pl) Sposób hodowli komórek
EP2980202A4 (de) Zellkulturvorrichtung und zellkulturverfahren
EP2924110A4 (de) Zellkulturvorrichtung und zellkulturverfahren
SG11201507338PA (en) Method for culturing cells
GB201308905D0 (en) Cell culture
GB201306488D0 (en) Cell culture
AU2013904257A0 (en) Cell culture method
EP2947157A4 (de) Verfahren zur identifizierung von zellen
GB201307708D0 (en) Method for cell enrichment